−1.28EUR
−5.16 MEUR
7.25 MEUR
5.92 M
About FRESH TRACKS THERAPEUTICS INC
Sector
CEO
Albert N. Marchio
Headquarters
Boulder
Website
Employees (FY)
4
Founded
2009
ISIN
US10802T2042
Fresh Tracks Therapeutics, Inc. engages in the development of prescription therapeutics for the treatment of skin diseases. Its pipeline consists of new molecular entities targeting the treatment of the following indications: hyperhidrosis, allergic contact dermatitis, androgenic alopecia, cutaneous t-cell lymphoma and psoriasis. The company was founded by Reginald L. Hardy and Andrew D. Sklawer in 2009 and is headquartered in Boulder, CO.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of VCC is 0.80 EUR — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange FRESH TRACKS THERAPEUTICS INC stocks are traded under the ticker VCC.
FRESH TRACKS THERAPEUTICS INC is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
VCC stock is 0% volatile and has beta coefficient of −1.25. Check out the list of the most volatile stocks — is FRESH TRACKS THERAPEUTICS INC there?
VCC earnings for the last quarter are −0.36 EUR per share, whereas the estimation was −1.54 EUR resulting in a 76.79% surprise. The estimated earnings for the next quarter are −0.57 EUR per share. See more details about FRESH TRACKS THERAPEUTICS INC earnings.
FRESH TRACKS THERAPEUTICS INC revenue for the last quarter amounts to 91.68 K EUR despite the estimated figure of 458.40 K EUR. In the next quarter revenue is expected to reach 4.26 M EUR.
Yes, you can track FRESH TRACKS THERAPEUTICS INC financials in yearly and quarterly reports right on TradingView.
VCC net income for the last quarter is −1.12 M EUR, while the quarter before that showed 1.80 M EUR of net income which accounts for −162.17% change. Track more FRESH TRACKS THERAPEUTICS INC financial stats to get the full picture.
Today FRESH TRACKS THERAPEUTICS INC has the market capitalization of 5.11 M, it has decreased by 6.55% over the last week.
No, VCC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, VCC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade FRESH TRACKS THERAPEUTICS INC stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 4.00 employees. See our rating of the largest employees — is FRESH TRACKS THERAPEUTICS INC on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So FRESH TRACKS THERAPEUTICS INC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating FRESH TRACKS THERAPEUTICS INC stock shows the sell signal. See more of FRESH TRACKS THERAPEUTICS INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. FRESH TRACKS THERAPEUTICS INC EBITDA is −5.69 M EUR, and current EBITDA margin is −78.93%. See more stats in FRESH TRACKS THERAPEUTICS INC financial statements.